Phenomenex and ChromaDex® Announces Collaboration Agreement
News Oct 03, 2012
Phenomenex Inc. and ChromaDex® Corporation have announced a collaboration agreement that will provide solutions to customers with a combination of reference standards, scientifically valid methods and application support.
The collaboration combines Phenomenex’s strengths in analytical HPLC (high-performance liquid chromatography) with ChromaDex’s extensive line of reference standards, which are used for quality control in dietary supplement manufacturing.
The first three new solutions will be presented as scientific posters at the AOAC (Association of Analytical Communities) annual meeting in Las Vegas next week and will be available as technical notes, the first of which can be viewed at www.phenomenex.com/cdpr.
The FDA has increased its scrutiny of the supplement industry in recent years, precipitating a need for faster, more advanced quality control methods.
“The ability to provide a complete package of reference standards and scientifically valid methods strengthens our leadership position and provides a ‘one stop shop’ for our customers,” said Frank Jaksch, CEO and founder of ChromaDex.
Jaksch continued, “The collaboration will deliver tools to help customers meet FDA guidance on cGMP (current good manufacturing practices) for dietary supplements.”
Phenomenex maintains a full-service analytical support laboratory, staffed with application scientists who specialize in method development and customized solutions.
This team will optimize methods for ChromaDex reference standards, based on the most advanced chromatography technology.
This includes working with a variety of sample matrices and will in many cases include the use of Phenomenex’s core-shell particle technology and Kinetex® columns.
“This collaboration is consistent with our strategy of providing the most complete solutions to the customers we serve,” explains Sky Countryman, manager of PhenoLogix and applied technology for Phenomenex. “We look forward to expanding our involvement with the growing dietary supplement market.”
Screening for Disease or Toxins in a Drop of BloodNews
Scientist have developed a multinozzle emitter array (MEA), a silicon chip that can dramatically shorten the time it takes to identify proteins, peptides, and other molecular components within small volumes of biological samples.READ MORE
Researchers Reveal How Superbug Secretes It’s ToxinNews
Monash University’s Biomedicine Discovery Institute (BDI) researchers have created the first high-resolution structure depicting a crucial part of the ‘superbug’ Pseudomonas aeruginosa. The image identifies the ‘nanomachine’ used by the highly virulent bacteria to secrete toxins, pointing the way for drug design targeting this.READ MORE